Antibiotics did not make appendectomy obsolete. They made success negotiable

Dr. Gerald A. Duffy, assisted by chief resident Dr. S. Yamada and the Amache hospital team, performs an emergency appendectomy on December 8, 1942. The War Relocation Authority photograph documents how thoroughly appendectomy had become an emergency standard by mid-century; it also records medicine practiced inside a U.S. incarceration camp. National Archives.[8]

In 1886, Harvard pathologist Reginald Heber Fitz gave a dangerous abdominal illness a more precise name and a more urgent clock. What physicians had often called typhlitis or perityphlitis—inflammation around the cecum—was, in many fatal cases, perforation of the vermiform appendix. Fitz's paper made early diagnosis valuable because it made early operative intervention imaginable. Waiting was not neutral when delay could end in abscess, diffuse peritonitis, and death.[1][2]

For more than a century, appendectomy inherited the moral force of that reconstruction: find the inflamed appendix before it ruptures, remove the source, and close the case. Modern antibiotics-first trials did not prove that this history was foolish. They asked a question Fitz could not ask in 1886: Can imaging identify a subgroup whose appendicitis is uncomplicated enough that an operation is an option rather than an inevitability?

The latest long-term evidence makes the answer awkward in the most useful way. In the Finnish APPAC trial, 44.3% of adults initially assigned to antibiotics had undergone appendectomy by 10 years. Read from the other side, 55.7% had not. Antibiotics did not make appendectomy obsolete. They made the definition of success negotiable: one definitive procedure now, or a chance to avoid it while accepting a substantial future risk of recurrence and surgery.[4]

Image context: the cover photograph was made at the Granada Relocation Center, better known as Amache, in Colorado on December 8, 1942. Dr. Gerald Duffy and chief resident Dr. S. Yamada are identified in the government caption. The image is evidence of appendectomy's mid-century status—a procedure expected even in an improvised hospital inside a wartime incarceration camp—not a neutral portrait of American medical progress.[8]

Six dates that changed the question

June 18, 1886: Fitz presented Perforating Inflammation of the Vermiform Appendix, linking a named organ, a recognizable syndrome, perforation, and the case for early intervention.[1][2]
December 8, 1942: a War Relocation Authority photographer documented an emergency appendectomy at Amache, by then an established response that could be carried into a confined hospital system.[8]
November 2009–June 2012: six Finnish hospitals enrolled adults in APPAC, but only after CT had excluded an appendicolith, perforation, abscess, or suspected tumor.[3]
June 2015: APPAC reported that 72.7% of evaluable antibiotic-assigned patients had avoided appendectomy at one year, even though the trial did not meet its prespecified noninferiority threshold.[3]
October 2020: the larger U.S. CODA trial found similar 30-day health status after an antibiotics-first strategy while exposing the extra risk carried by an appendicolith.[5]
January 28, 2026: updated World Society of Emergency Surgery guidance kept both conclusions in view: antibiotics are safe and effective for selected uncomplicated cases, while laparoscopic appendectomy remains the standard operation.[7]

Surgery won by turning uncertainty into source control

The strongest surgical argument is causal, not traditional. An inflamed appendix can progress to necrosis, perforation, abscess, or generalized infection. Removing it ends the immediate disease process and supplies tissue for pathological examination. The patient does not have to wonder whether the same appendix will inflame again.

Fitz's intervention mattered because it relocated the suspected source. His 1886 analysis challenged a vocabulary that centered the cecum and surrounding tissues, then argued that the appendix was commonly the perforated structure in fatal cases.[1] Surgeons soon paired that pathological claim with earlier operations, better anesthesia, antisepsis, and repeatable incisions. The historical overview by Ceresoli and colleagues traces how appendectomy moved from scattered, hazardous cases in the late nineteenth century toward a standard treatment as diagnosis and operative technique improved.[2]

That history produced a reasonable asymmetry. A patient who recovered after surgery demonstrated that the diseased organ had been removed. A patient who improved without surgery might have had self-limited inflammation, a mistaken diagnosis, or a temporary remission before recurrence. Surgery generated its own proof; nonoperative recovery remained harder to interpret.

The weakness in the strongest surgical story is the assumption that every inflamed appendix is on the same conveyor belt toward perforation. If some uncomplicated cases resolve, then immediate removal prevents a future that was never certain while imposing an operation whose complications are real. The antibiotics debate could begin only when diagnosis became precise enough to separate that possibility from the much riskier problem of complicated appendicitis.

Antibiotics became plausible because CT created a narrower disease

APPAC did not randomize everyone arriving with right-lower-quadrant pain. It enrolled 530 adults aged 18 to 60 with CT-confirmed uncomplicated appendicitis. The trial excluded patients whose scans showed an appendicolith—a calcified deposit within the appendix—along with perforation, abscess, or suspected tumor. It also excluded pregnancy, peritonitis, serious systemic illness, and several barriers to contrast CT or the study drugs.[3]

That selection is not fine print. It created the object being debated. “Appendicitis” in Fitz's paper was reconstructed from clinical courses, operations, and autopsies, with perforation at the center. “Uncomplicated appendicitis” in APPAC was a radiologically filtered category designed to remove features most likely to make waiting dangerous or antibiotic failure more likely.

The original APPAC result can therefore support two honest headlines. Appendectomy was technically successful in 99.6% of surgical patients. In the antibiotics group, 27.3% underwent appendectomy within one year, meaning the prespecified noninferiority test failed. Yet 186 of 256 evaluable antibiotic-assigned patients—72.7%—had avoided surgery at that point, and delayed operations did not produce the feared wave of major complications.[3]

One headline treats any later appendectomy as failure. The other treats every avoided appendectomy as a benefit. Neither definition is a laboratory fact. Each encodes what the patient and trial designer value.

The 10-year result preserved the tradeoff

APPAC's 2026 follow-up assessed 253 of the 257 people originally assigned to antibiotics. By 10 years, the histologically confirmed recurrence rate was 37.8% and the cumulative appendectomy rate was 44.3%. The difference matters: some patients had surgery for suspected recurrence without appendicitis being confirmed, so “eventual operation” and “proven recurrent disease” were not identical outcomes.[4]

The complication ledger leaned the other way. The reported 10-year cumulative complication rate was 27.4% among those originally assigned to appendectomy and 8.5% among those assigned to antibiotics. Median quality-of-life scores did not differ significantly. The surgical group bought finality at the cost of more recorded treatment complications; the antibiotics group bought a chance to avoid those harms at the cost of recurrence, repeat uncertainty, and a sizeable probability of later surgery.[4]

This is why the same dataset does not crown a universal winner. A person who considers recurrence and another emergency visit intolerable may see 44.3% as decisive evidence for appendectomy. A person who strongly wants to avoid an operation may see 55.7% still appendix-intact at 10 years as a worthwhile chance. Evidence can bound the wager without choosing the value placed on each outcome.

APPAC also has a boundary: it tested a tightly selected Finnish adult population with a specific, intensive antibiotic regimen and excluded appendicoliths. Its result cannot be silently extended to every child, pregnant patient, older adult, immunocompromised patient, or person with perforation or abscess.[3][4][7]

CODA put the stone back into the picture

The U.S. CODA trial deliberately broadened the test. At 25 centers it randomized 1,552 adults, including 414 with an appendicolith, to a 10-day antibiotics strategy or appendectomy. At 30 days, antibiotics were noninferior on the trial's general health-status measure: the mean EQ-5D difference was 0.01 points, with a 95% confidence interval from −0.001 to 0.03.[5]

But equal short-term health status did not mean equal treatment paths. By 90 days, 29% of the antibiotics group had undergone appendectomy. The rate was 41% with an appendicolith and 25% without one. Overall complications were more common after antibiotic assignment, but that excess was concentrated among participants with an appendicolith; without a stone, the complication rates were similar between strategies.[5]

Longer CODA follow-up showed the conversion continuing rather than stopping at 90 days: appendectomy after antibiotic assignment reached 40% at one year, 46% at two years, and 49% at three to four years.[6] This did not erase the short-term quality-of-life finding. It revealed what that finding could not answer. Feeling no worse at 30 days and avoiding surgery for years are different outcomes.

CODA therefore strengthens both sides of the map. It shows that an antibiotics-first pathway can work in ordinary U.S. practice, sometimes without initial hospitalization. It also shows that imaging features—especially an appendicolith—change the odds enough that “antibiotics versus surgery” is too blunt a question.[5][6]

The modern consensus is conditional on purpose

The 2025 edition of the World Society of Emergency Surgery's Jerusalem guidelines, published in 2026, does not announce a winner. It says nonoperative management with antibiotics is safe and effective in selected patients with uncomplicated appendicitis, with recommendations tailored to different populations. In the same synthesis, laparoscopic appendectomy remains the standard surgical approach. Imaging and clinical risk scores matter because the choice depends on diagnosing the right category before discussing preferences.[7]

That is not indecision. It is a more exact settlement than either slogan permits:

Appendectomy offers finality. It removes the current source, largely eliminates recurrence from that appendix, and avoids betting that imaging has correctly excluded a more dangerous process. It carries anesthesia, operative, wound, and longer-term surgical risks.
Antibiotics offer optionality. In selected uncomplicated adult cases, they give a meaningful chance of avoiding surgery, including over long follow-up. They preserve the appendix but also preserve the possibility of recurrence, further care, and later appendectomy.
Selection changes the comparison. An appendicolith, perforation, abscess, suspected tumor, pregnancy, age, immune status, and local diagnostic resources can move a patient outside the population in which the cleanest trial claims were made.[3][5][7]

What evidence would redraw the map?

The antibiotics interpretation would weaken if longer follow-up showed a continuing rise in dangerous recurrences, missed tumors, or cumulative harms that erased the early advantage of avoiding surgery. It would strengthen if better clinical and imaging markers reliably identified who could recover without recurrence, and if simpler antibiotic regimens reproduced the results across health systems.

The automatic-surgery interpretation would regain ground if appendectomy produced clearly better survival, major-complication, or durable quality-of-life outcomes in properly selected uncomplicated cases. It would weaken further if trials showed that observation or narrower antibiotic use could safely spare still more operations. The small APPAC III placebo comparison has already made spontaneous resolution a live research question, but it is not yet a license to replace an established treatment pathway with watchful waiting.[7]

The durable lesson is narrower than “antibiotics cure appendicitis” and more interesting than “surgery is outdated.” Fitz helped medicine see that delay could be lethal when an appendix was perforating. Modern trials helped medicine see that not every imaging-confirmed uncomplicated case shares that trajectory. The argument changed because the disease category changed—and because success expanded from Was the appendix removed? to Which risks did this person most want to avoid?

This article is a history of evidence, not a diagnostic or treatment guide. Suspected appendicitis still requires prompt clinical assessment; the trials do not support self-treatment, leftover antibiotics, or waiting at home to learn whether pain will pass.

cronfeed.work